True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: A model linking chronic infection to chronic sialadenitis

Israel Medical Association Journal

Volumn 4, Issue 12, 2002, Pages 1101-1105

  De Vita, Salvatore ^a   Damato, Rosaria ^a   De Marchi, Ginevra ^a   Sacco, Stefania ^a   Ferraccioli, Gianfranco ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Classification; Hepatitis C; Lymphoma; Sj gren's syndrome

Indexed keywords

ANTIBODIES; ASSAYS; BIOPSY; PATHOLOGY; SWELLING;

HEPATITIS C VIRUS INFECTIONS;

PATIENT MONITORING;

ANTIBODY; ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; HEPATITIS C ANTIBODY; RHEUMATOID FACTOR; SJOEGREN SYNDROME A ANTIBODY; SJOEGREN SYNDROME B ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CHRONIC DISEASE; CHRONIC GASTRITIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE CLASSIFICATION; DRY EYE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROMYALGIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; LIVER DISEASE; LUNG DISEASE; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; MALE; MODEL; MUCOSA INFLAMMATION; NONHUMAN; PATHOLOGY; PERIPHERAL NEUROPATHY; PURPURA; SALIVARY GLAND BIOPSY; SHIRMER TEST; SIALOADENITIS; SIALOMETRY; SJOEGREN SYNDROME; XEROSTOMIA;

AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; BIOPSY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; RHEUMATOID FACTOR; SALIVARY GLANDS; SJOGREN'S SYNDROME; STATISTICS, NONPARAMETRIC;

EID: 0036925601     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339(8789)321-3.
2. Ramos-Casals M, Garcia-Carrasco M, Cervera R, Font J. Sjögren's syndrome and hepatitis C virus. Clin Rheumatol 1999; 18(2):93-100.
3. Ramos-Casals M, Garcia-Carrasco M, Cervera R, et al. Hepatitis C virus infection mimicking primary Sjögren's syndrome. A clinical and immunologic description of 35 cases. Medicine 2001;80(1):1-8.
4. Loustaud-Ratti V, Riche A, Liozon E, et al. Prevalence and characteristics of Sjögren's syndrome or sicca syndrome in chronic hepatitis C virus infection: A prospective study. J Rheumatol 2001;28(10):2245-51.
5. De Vita S, Sansonno D, Dolcetti R, et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995;86(5):1887-92.
6. Arrieta JJ, Rodriguez-Inigo E, Ortiz-Movilla N, et al. In situ detection of hepatitis C virus RNA in salivary glands. Am J Pathol 2001;158(1):259-64.
7. Koike K, Moriya K, Ishibashi K, et al. Expression of hepatitis C virus envelope proteins in transgenic mice. J Gen Virol 1995;76(Pt 12):3031-8.
8. De Vita S, Sacco C, Sansonno D, et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 1997;90(2):776-82.
9. De Vita S, Zagonel V, Russo A, et al. Hepatitis C virus non-Hodgkin's lymphomas and hepatocellular carcinoma. Br J Cancer 1998;77(11):2032-5.
10. De Vita S, De Marchi G, Sacco S, Gremese E, Fabris M, Ferraccioli GF. Preliminary classification of nonmalignant B cell proliferation in Sjögren's syndrome: Perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular approach. Blood Cells Mol Dis 2001;27(4):757-66.
11. Fox R, Tornwall J, Michelson P. Current issues in the diagnosis and treatment of Sjögren's syndrome. Curr Opin Rheumatol 1999;11(5):364-71.
12. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36(3):340-7.
13. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61(6):554-8.
14. Manns MP, McHutchinson JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001;358(9286):958-65.
15. De Vita S, Boiocchi M, Sorrentino D, et al. Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. Arthritis Rheum 1997;40(2):318-31.
16. Moutsopoulos HM, Tzioufas AG. Sjögren's syndrome. In: Klippel JH, Dieppe PA, eds. Rheumatology. London: Mosby, 1994;6.27.1-12.
17. Scott CA, Avellini C, Desinan L, et al. Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: Comparison with Sjögren's syndrome. Histopathology 1997;30(1):41-8.
18. Dispenzieri A, Gorevic PD. Cryoglobulinemia. Hematol Oncol Clin North Am 1999;13(6):1315-49.
19. De Re V, De Vita S, Gasparotto D, et al. Salivary gland non-neoplastic B-cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen-receptor gene segments similar to those used by hepatitis C virus-associated non Hodgkin's lymphomas. Eur J Immunol 2002;32(3):903-10.
20. De Vita S, De Re V, Sansonno D, et al. Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: Viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis. Hepatology 2000;31(1):182-9.
21. De Vita S, De Re V, Gasparotto D, et al. Oligoclonal non neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia. Arthritis Rheum 2000;43(1):94-102.
22. Corper AL, Sohi MK, Bonagura VR, et al. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nat Struct Biol 1997;4(5):374-81.
23. De Re V, De Vita S, Marzotto A, et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 2000;96(10):3578-84.
24. Chan CH, Hadlock KG, Foung SK, Levy S. V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 2001;97(4):1023-6.
25. Quinn ER, Chan CH, Hadlock KG, Foung SK, Flint M, Levy S. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001;98(13):3745-9.